Rho Kinase as a Novel Molecular Therapeutic Target for Hypertensive Internal Anal Sphincter

Gastroenterology

Volumn 131, Issue 1, 2006, Pages 108-116

  Rattan, Satish ^a   De Godoy, Marcio A F ^a   Patel, Chirag A ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; HEXAMETHONIUM; ISOENZYME; PROPRANOLOL; RHO KINASE; RHO KINASE II; RHO KINASE INHIBITOR; TETRODOTOXIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ANORECTAL PRESSURE; ANUS SPHINCTER DISORDER; ARTICLE; CARDIOVASCULAR DISEASE; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG POTENCY; ENZYME ACTIVITY; HYPERTENSIVE INTERNAL ANAL SPHINCTER; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; RAT; RECTUM; SMOOTH MUSCLE; SMOOTH MUSCLE FIBER; SMOOTH MUSCLE RELAXATION;

EID: 33745852280     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2006.03.043     Document Type: Article

References (45)

1. Schiller L.R. Fecal incontinence. In: Feldman M. (Ed). Sleisenger & Fordrtran's gastrointestinal and liver disease. 7th ed. (2002), Saunders, Philadelphia, PA 164-174
2. Lennard-Jones J.E. Constipation. In: Feldman M. (Ed). Sleisenger & Fordtan's gastrointestinal and liver disease. 7th ed. (2002), Saunders, Philadelphia, PA 181-210
3. O'Kelly T.J., Davies J.R., Tam P.K., Brading A.F., and Mortensen N.J.M.C. Abnormalities of nitric-oxide-producing neurons in Hirschsprung's disease. morphology and implications. J Pediatr Surg 29 (1994) 294-300
4. Vanderwinden J.-M., De Laet M.-H., Schiffmann S.N., Mailleux P., Lowenstein C.J., Snyder S.H., and Vanderhaeghen J.-J. Nitric oxide synthase distribution in the enteric nervous system of Hirschsprung's disease. Gastroenterology 105 (1993) 969-973
5. Rattan S. The internal anal sphincter. regulation of smooth muscle tone and relaxation. Neurogastroenterol Motil 17 (2005) 50-59
6. McCallion K., and Gardiner K.R. Progress in the understanding and treatment of chronic anal fissure. Postgrad Med J 77 (2002) 753-758
7. Madoff R.D., and Fleshman J.W. American Gastroenterological Association technical review on the diagnosis and treatment of hemorrhoids. Gastroenterology 126 (2004) 1463-1473
8. Culver P.J., and Rattan S. Genesis of anal canal pressures in the opossum. Am J Physiol Gastrointest Liver Physiol 251 (1986) G765-G771
9. Harnett K.M., and Biancani P. Calcium-dependent and calcium-independent contractions in smooth muscles. Am J Med 115 (2003) 24S-30S
10. Harnett K.M., Cao W., and Biancani P. Signal-transduction pathways that regulate smooth muscle function. Signal transduction in phasic (esophageal) and tonic (gastroesophageal sphincter) smooth muscles. Am J Physiol Gastrointest Liver Physiol 288 (2005) G407-G416
11. Cao W., Sohn U.D., Bitar K.N., Biancani P., and Harnett K.M. MAPK mediates PKC-dependent contractions of cat esophageal and lower esophageal sphincter circular smooth muscle. Am J Physiol Gastrointest Liver Physiol 285 (2003) G86-G95
12. 20 (20 kDa regulatory light chain myosin II) phosphorylation via Rho-associated kinase/myosin phosphatase targeting subunit and protein kinase C/CPI-17 pathway. Biochem J 374 (2003) 145-155
13. 2+ mediated by distinct PKC isozymes. Am J Physiol Gastrointest Liver Physiol 279 (2000) G201-G210
14. Knight J.S., Birks M., and Farouk R. Topical diltiazem ointment in the treatment of chronic anal fissure. Br J Surg 88 (2001) 453-456
15. Jones O.M., Brading A.F., and Mortensen N.J. The physiology, pharmacology, and therapeutic manipulation of the internal anal sphincter. Can J Gastroenterol 16 (2002) 249-257
16. Altmore D.F., Rinaldi M., and Miltito G. Glyceryl trinitrate for chronic anal fissure-healing or headache. Dis Colon Rectum 43 (2000) 174-181
17. Maria G., Brisinda G., Bentivoglio A.R., Cassetta E., Gui D., and Albanese A. Botulinum toxin injections in the internal anal sphincter for the treatment of chronic anal fissure. long-term results after two different dosage regimens. Ann Surg 228 (1998) 664-669
18. Hoogerwerf W.A., and Pasricha P.J. Botulinum toxin for spastic gastrointestinal disorders. Baillieres Best Pract Res Clin Gastroenterol 13 (1999) 131-143
19. Torrabadella L., Salgado G., Burns R.W., and Berman I.R. Manometric study of topical sildenafil (Viagra) in patients with chronic anal fissure. sildenafil reduces anal resting tone. Dis Colon Rectum 47 (2004) 733-738
20. Milone M., and DiBaise J.D. A pilot study of the effects of sildenafil on stool characteristics, colon transit, anal sphincter function, and rectal sensation in healthy men. Dig Dis Sci 50 (2005) 1005-1011
21. Manallack D.T., Hughes R.A., and Thompson P.E. The next generation of phosphodiesterase inhibitors. structural clues to ligand and substance selectivity of phosphodiesterases. J Med Chem 48 (2005) 3449-3462
22. Murthy K.S., Zhou H., Grider J.R., and Makhlouf G.M. Inhibition of sustained smooth muscle contraction by PKA and PKG preferentially mediated by phosphorylation of rhoA. Am J Physiol Gastrointest Liver Physiol 284 (2003) G1006-G1016
23. Rattan S., Sarkar A., and Chakder S. Nitric oxide pathway in rectoanal inhibitory reflex of opossum internal anal sphincter. Gastroenterology 103 (1992) 43-50
24. Goyal R.K., and Hirano I. The enteric nervous system. N Engl J Med 334 (1996) 1106-1115
25. Goyal R.K. Targets of enteric motor neurones. smooth muscle cells. Gut 47 Suppl IV (2000) iv38-iv39
26. Takahashi T. Pathophysiological significance of neuronal nitric oxide synthase in the gastrointestinal tract. J Gastroenterol 38 (2003) 421-430
27. Ishizaki T., Uehata M., Tamechika I., Keel J., Nonomura K., and Maekawa M. Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases. Mol Pharmacol 57 (2000) 976-983
28. Rattan S., and Chakder S. Role of nitric oxide as a mediator of internal anal sphincter relaxation. Am J Physiol Gastrointest Liver Physiol 262 (1992) G107-G112
29. Rattan S., Al Haj R., and De Godoy M.A.F. Mechanism of internal anal sphincter relaxation by CORM-1, authentic CO, and NANC nerve stimulation. Am J Physiol Gastrointest Liver Physiol 287 (2004) G605-G611
30. De Godoy M.A.F., and Rattan S. Autocrine regulation of internal anal sphincter tone by renin-angiotensin system. comparison with phasic smooth muscle. Am J Physiol Gastrointest Liver Physiol 289 (2005) G1164-G1175
31. Rattan S., Regan R.F., Patel C.A., and De Godoy M.A.F. Nitric oxide not carbon monoxide mediates nonadrenergic noncholinergic relaxation in the murine internal anal sphincter. Gastroenterology 129 (2005) 1954-1966
32. Biancani P., Walsh J.H., and Behar J. Vasoactive intestinal polypeptide. a neurotransmitter for relaxation of the rabbit internal anal sphincter. Gastroenterology 89 (1985) 867-874
33. Terauchi A., Kobayashi D., and Mashimo H. Distinct roles of constitutive nitric oxide synthases and interstitial cells of Cajal in rectoanal relaxation. Am J Physiol Gastrointest Liver Physiol 289 (2005) G291-G299
34. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 193 (1951) 265-275
35. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260 (1985) 3440-3450
36. Chakder S., Sarma D., and Rattan S. Mechanism of internal anal sphincter smooth muscle relaxation by phorbol 12,13-dibutyrate. Am J Physiol Gastrointest Liver Physiol 280 (2001) G1341-G1350
37. O'Kelly T., Brading A., and Mortensen N. Nerve mediated relaxation of the human internal anal sphincter. the role of nitric oxide. Gut 34 (1993) 689-693
38. 2+ sensitivity of smooth muscle and nonmuscle myosin II. modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev 83 (2003) 1325-1358
39. Ito M., Nakano T., Erdodi F., and Hartshorne D.J. Myosin phosphatase. structure, regulation and function. Mol Cell Biochem 259 (2004) 197-209
40. Budzyn K., Marley P.D., and Sobey C.G. Targeting Rho and Rho-kinase in the treatment of cardiovascular disease. Trends Pharmacol Sci 27 (2006) 97-104
41. Cook T.A., Brading A.F., and Mortensen N.J. The pharmacology of the internal anal sphincter and new treatments of ano-rectal disorders. Aliment Pharmacol Ther 15 (2001) 887-898
42. v mutant mice. Gastroenterology 121 (2001) 34-42
43. Seftel A.D. Phosphodiesterase type 5 inhibitors. molecular pharmacology and interactions with other phosphodiesterases. Curr Pharm Des 1 (2005) 4047-4058
44. Murthy K.S. Signaling for contraction and relaxation in smooth muscle of the gut. Annu Rev Physiol 68 (2006) 345-374
45. Chakder S., McHugh K.M., and Rattan S. Inhibitory neurotransmission in lethal spotted mutant mice. a model for Hirschsprung's disease. Gastroenterology 112 (1997) 1575-1585